The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:

"
Death Domain, Fas
".

Functional Families

Overview of the Structural Clusters (SC) and Functional Families within this CATH Superfamily. Clusters with a representative structure are represented by a filled circle.
« Back to all FunFams

FunFam 22: B-cell lymphoma/leukemia 10

Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.

There are 40 GO terms relating to "molecular function"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Protein C-terminus binding GO:0008022
Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxyl function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Kinase binding GO:0019900
Interacting selectively and non-covalently with a kinase, any enzyme that catalyzes the transfer of a phosphate group.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Ubiquitin protein ligase binding GO:0031625
Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Protein kinase B binding GO:0043422
Interacting selectively and non-covalently with protein kinase B, an intracellular kinase that is important in regulating glucose metabolism.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Protein self-association GO:0043621
Interacting selectively and non-covalently with a domain within the same polypeptide.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
NF-kappaB binding GO:0051059
Interacting selectively and non-covalently with NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
7 E7EC82 (/IPI) O95999 (/IPI) O95999 (/IPI) Q9QYN5 (/IPI) Q9Z0H7 (/IPI) Q9Z0H7 (/IPI) R4GI14 (/IPI)
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
2 O95999 (/IPI) O95999 (/IPI)
Protease binding GO:0002020
Interacting selectively and non-covalently with any protease or peptidase.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
2 O95999 (/IDA) O95999 (/IDA)
Transcription coactivator activity GO:0003713
A protein or a member of a complex that interacts specifically and non-covalently with a DNA-bound DNA-binding transcription factor to activate the transcription of specific genes. Coactivators often act by altering chromatin structure and modifications. For example, one class of transcription coregulators modifies chromatin structure through covalent modification of histones. A second ATP-dependent class modifies the conformation of chromatin. Another type of coregulator activity is the bridging of a DNA-binding transcription factor to the basal transcription machinery. The Mediator complex, which bridges transcription factors and RNA polymerase, is also a transcription coactivator.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Protein C-terminus binding GO:0008022
Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxyl function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
2 O95999 (/IPI) O95999 (/IPI)
Protein C-terminus binding GO:0008022
Interacting selectively and non-covalently with a protein C-terminus, the end of any peptide chain at which the 1-carboxyl function of a constituent amino acid is not attached in peptide linkage to another amino-acid residue.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
2 O95999 (/IPI) O95999 (/IPI)
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Cysteine-type endopeptidase activator activity involved in apoptotic process GO:0008656
Increases the rate of proteolysis catalyzed by a cysteine-type endopeptidase involved in the apoptotic process.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
2 O95999 (/IPI) O95999 (/IPI)
Enzyme binding GO:0019899
Interacting selectively and non-covalently with any enzyme.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Kinase binding GO:0019900
Interacting selectively and non-covalently with a kinase, any enzyme that catalyzes the transfer of a phosphate group.
2 O95999 (/IPI) O95999 (/IPI)
Kinase binding GO:0019900
Interacting selectively and non-covalently with a kinase, any enzyme that catalyzes the transfer of a phosphate group.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
2 O95999 (/IDA) O95999 (/IDA)
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Ubiquitin protein ligase binding GO:0031625
Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
2 O95999 (/IPI) O95999 (/IPI)
Ubiquitin protein ligase binding GO:0031625
Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
2 O95999 (/IPI) O95999 (/IPI)
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Protein homodimerization activity GO:0042803
Interacting selectively and non-covalently with an identical protein to form a homodimer.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Protein kinase B binding GO:0043422
Interacting selectively and non-covalently with protein kinase B, an intracellular kinase that is important in regulating glucose metabolism.
2 O95999 (/IPI) O95999 (/IPI)
Protein kinase B binding GO:0043422
Interacting selectively and non-covalently with protein kinase B, an intracellular kinase that is important in regulating glucose metabolism.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Protein self-association GO:0043621
Interacting selectively and non-covalently with a domain within the same polypeptide.
2 O95999 (/IPI) O95999 (/IPI)
Protein self-association GO:0043621
Interacting selectively and non-covalently with a domain within the same polypeptide.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
CARD domain binding GO:0050700
Interacting selectively and non-covalently with a CARD (N-terminal caspase recruitment) domain, a protein-protein interaction domain that belongs to the death domain-fold superfamily. These protein molecule families are similar in structure with each consisting of six or seven anti-parallel alpha-helices that form highly specific homophilic interactions between signaling partners. CARD exists in the N-terminal prodomains of several caspases and in apoptosis-regulatory proteins and mediates the assembly of CARD-containing proteins that participate in activation or suppression of CARD carrying members of the caspase family.
2 O95999 (/IPI) O95999 (/IPI)
CARD domain binding GO:0050700
Interacting selectively and non-covalently with a CARD (N-terminal caspase recruitment) domain, a protein-protein interaction domain that belongs to the death domain-fold superfamily. These protein molecule families are similar in structure with each consisting of six or seven anti-parallel alpha-helices that form highly specific homophilic interactions between signaling partners. CARD exists in the N-terminal prodomains of several caspases and in apoptosis-regulatory proteins and mediates the assembly of CARD-containing proteins that participate in activation or suppression of CARD carrying members of the caspase family.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
NF-kappaB binding GO:0051059
Interacting selectively and non-covalently with NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters.
2 O95999 (/IDA) O95999 (/IDA)
NF-kappaB binding GO:0051059
Interacting selectively and non-covalently with NF-kappaB, a transcription factor for eukaryotic RNA polymerase II promoters.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Caspase binding GO:0089720
Interacting selectively and non-covalently with a caspase family protein.
1 E7EC82 (/IPI)

There are 81 GO terms relating to "biological process"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Neural tube closure GO:0001843
The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
9 E7EC82 (/ISS) O95999 (/ISS) O95999 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS)
Response to molecule of bacterial origin GO:0002237
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Negative regulation of mature B cell apoptotic process GO:0002906
Any process that stops, prevents, or reduces the frequency, rate, or extent of mature B cell apoptotic process.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Cell death GO:0008219
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538).
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Positive regulation of protein ubiquitination GO:0031398
Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Response to food GO:0032094
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a food stimulus; food is anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Positive regulation of phosphorylation GO:0042327
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123
Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Positive regulation of interleukin-8 biosynthetic process GO:0045416
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
T cell receptor signaling pathway GO:0050852
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Protein complex oligomerization GO:0051259
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Protein homooligomerization GO:0051260
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
9 E7EC82 (/ISS) O95999 (/ISS) O95999 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS)
Positive regulation of extrinsic apoptotic signaling pathway GO:2001238
Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Positive regulation of extrinsic apoptotic signaling pathway GO:2001238
Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway.
4 O95999 (/IDA) O95999 (/IDA) Q9Z0H7 (/IDA) Q9Z0H7 (/IDA)
Adaptive immune response GO:0002250
An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
3 Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
3 O95999 (/IDA) O95999 (/IDA) Q9QYN5 (/IDA)
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
3 E7F8A6 (/IDA) O95999 (/IDA) O95999 (/IDA)
B cell apoptotic process GO:0001783
Any apoptotic process in a B cell, a lymphocyte of B lineage with the phenotype CD19-positive and capable of B cell mediated immunity.
2 Q9Z0H7 (/IDA) Q9Z0H7 (/IDA)
Neural tube closure GO:0001843
The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
2 Q9Z0H7 (/IMP) Q9Z0H7 (/IMP)
Stimulatory C-type lectin receptor signaling pathway GO:0002223
Any series of molecular signals generated as a consequence of binding to a C-type lectin receptor capable of cellular activation.
2 O95999 (/TAS) O95999 (/TAS)
Toll-like receptor signaling pathway GO:0002224
Any series of molecular signals generated as a consequence of binding to a toll-like receptor. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
2 O95999 (/IDA) O95999 (/IDA)
Toll-like receptor signaling pathway GO:0002224
Any series of molecular signals generated as a consequence of binding to a toll-like receptor. Toll-like receptors directly bind pattern motifs from a variety of microbial sources to initiate innate immune response.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Response to molecule of bacterial origin GO:0002237
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus by molecules of bacterial origin such as peptides derived from bacterial flagellin.
2 O95999 (/IEP) O95999 (/IEP)
Adaptive immune response GO:0002250
An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
2 O95999 (/IMP) O95999 (/IMP)
Adaptive immune response GO:0002250
An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Adaptive immune response GO:0002250
An immune response mediated by cells expressing specific receptors for antigen produced through a somatic diversification process, and allowing for an enhanced secondary response to subsequent exposures to the same antigen (immunological memory).
2 O95999 (/TAS) O95999 (/TAS)
Negative regulation of mature B cell apoptotic process GO:0002906
Any process that stops, prevents, or reduces the frequency, rate, or extent of mature B cell apoptotic process.
2 O95999 (/IDA) O95999 (/IDA)
Negative regulation of mature B cell apoptotic process GO:0002906
Any process that stops, prevents, or reduces the frequency, rate, or extent of mature B cell apoptotic process.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Activation of cysteine-type endopeptidase activity involved in apoptotic process GO:0006919
Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Cellular defense response GO:0006968
A defense response that is mediated by cells.
2 Q9Z0H7 (/IMP) Q9Z0H7 (/IMP)
I-kappaB kinase/NF-kappaB signaling GO:0007249
The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
2 Q9Z0H7 (/IMP) Q9Z0H7 (/IMP)
I-kappaB kinase/NF-kappaB signaling GO:0007249
The process in which a signal is passed on to downstream components within the cell through the I-kappaB-kinase (IKK)-dependent activation of NF-kappaB. The cascade begins with activation of a trimeric IKK complex (consisting of catalytic kinase subunits IKKalpha and/or IKKbeta, and the regulatory scaffold protein NEMO) and ends with the regulation of transcription of target genes by NF-kappaB. In a resting state, NF-kappaB dimers are bound to I-kappaB proteins, sequestering NF-kappaB in the cytoplasm. Phosphorylation of I-kappaB targets I-kappaB for ubiquitination and proteasomal degradation, thus releasing the NF-kappaB dimers, which can translocate to the nucleus to bind DNA and regulate transcription.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Cell death GO:0008219
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538).
2 O95999 (/IDA) O95999 (/IDA)
Cell death GO:0008219
Any biological process that results in permanent cessation of all vital functions of a cell. A cell should be considered dead when any one of the following molecular or morphological criteria is met: (1) the cell has lost the integrity of its plasma membrane; (2) the cell, including its nucleus, has undergone complete fragmentation into discrete bodies (frequently referred to as apoptotic bodies). The cell corpse (or its fragments) may be engulfed by an adjacent cell in vivo, but engulfment of whole cells should not be considered a strict criteria to define cell death as, under some circumstances, live engulfed cells can be released from phagosomes (see PMID:18045538).
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Response to fungus GO:0009620
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a fungus.
2 Q9Z0H7 (/IMP) Q9Z0H7 (/IMP)
Immunoglobulin mediated immune response GO:0016064
An immune response mediated by immunoglobulins, whether cell-bound or in solution.
2 Q9Z0H7 (/IMP) Q9Z0H7 (/IMP)
Protein ubiquitination GO:0016567
The process in which one or more ubiquitin groups are added to a protein.
2 O95999 (/TAS) O95999 (/TAS)
Positive regulation of protein ubiquitination GO:0031398
Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
2 O95999 (/IDA) O95999 (/IDA)
Positive regulation of protein ubiquitination GO:0031398
Any process that activates or increases the frequency, rate or extent of the addition of ubiquitin groups to a protein.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
2 O95999 (/IDA) O95999 (/IDA)
Lipopolysaccharide-mediated signaling pathway GO:0031663
A series of molecular signals initiated by the binding of a lipopolysaccharide (LPS) to a receptor on the surface of a target cell, and ending with regulation of a downstream cellular process, e.g. transcription. Lipopolysaccharides are major components of the outer membrane of Gram-negative bacteria, making them prime targets for recognition by the immune system.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Response to food GO:0032094
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a food stimulus; food is anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat.
2 O95999 (/IDA) O95999 (/IDA)
Response to food GO:0032094
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a food stimulus; food is anything which, when taken into the body, serves to nourish or build up the tissues or to supply body heat.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Positive regulation of mast cell cytokine production GO:0032765
Any process that activates or increases the frequency, rate, or extent of mast cell cytokine production.
2 O95999 (/NAS) O95999 (/NAS)
Fc-epsilon receptor signaling pathway GO:0038095
A series of molecular signals initiated by the binding of the Fc portion of immunoglobulin E (IgE) to an Fc-epsilon receptor on the surface of a signal-receiving cell, and ending with regulation of a downstream cellular process, e.g. transcription. The Fc portion of an immunoglobulin is its C-terminal constant region.
2 O95999 (/TAS) O95999 (/TAS)
Lymphotoxin A biosynthetic process GO:0042109
The chemical reactions and pathways resulting in the formation of the cytokine lymphotoxin A.
2 O95999 (/NAS) O95999 (/NAS)
Interleukin-6 biosynthetic process GO:0042226
The chemical reactions and pathways resulting in the formation of interleukin-6.
2 O95999 (/NAS) O95999 (/NAS)
Positive regulation of phosphorylation GO:0042327
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.
2 O95999 (/IDA) O95999 (/IDA)
Positive regulation of phosphorylation GO:0042327
Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to a molecule.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123
Any process that activates or increases the frequency, rate or extent of I-kappaB kinase/NF-kappaB signaling.
2 O95999 (/IEP) O95999 (/IEP)
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
2 Q9Z0H7 (/IDA) Q9Z0H7 (/IDA)
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
2 O95999 (/IMP) O95999 (/IMP)
Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043280
Any process that activates or increases the activity of a cysteine-type endopeptidase involved in the apoptotic process.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Innate immune response GO:0045087
Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens.
2 O95999 (/IEP) O95999 (/IEP)
Positive regulation of interleukin-8 biosynthetic process GO:0045416
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.
2 O95999 (/IMP) O95999 (/IMP)
Positive regulation of interleukin-8 biosynthetic process GO:0045416
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of interleukin-8.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Mast cell activation GO:0045576
The change in morphology and behavior of a mast cell resulting from exposure to a cytokine, chemokine, soluble factor, or to (at least in mammals) an antigen which the mast cell has specifically bound via IgE bound to Fc-epsilonRI receptors.
2 Q9Z0H7 (/NAS) Q9Z0H7 (/NAS)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
2 O95999 (/IDA) O95999 (/IDA)
Positive regulation of transcription, DNA-templated GO:0045893
Any process that activates or increases the frequency, rate or extent of cellular DNA-templated transcription.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
T cell receptor signaling pathway GO:0050852
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
2 O95999 (/IDA) O95999 (/IDA)
T cell receptor signaling pathway GO:0050852
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
T cell receptor signaling pathway GO:0050852
A series of molecular signals initiated by the cross-linking of an antigen receptor on a T cell.
2 O95999 (/TAS) O95999 (/TAS)
Regulation of T cell receptor signaling pathway GO:0050856
Any process that modulates the frequency, rate or extent of signaling pathways initiated by the cross-linking of an antigen receptor on a T cell.
2 Q9Z0H7 (/IMP) Q9Z0H7 (/IMP)
Positive regulation of T cell activation GO:0050870
Any process that activates or increases the frequency, rate or extent of T cell activation.
2 Q9Z0H7 (/IMP) Q9Z0H7 (/IMP)
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
2 Q9Z0H7 (/IMP) Q9Z0H7 (/IMP)
Positive regulation of NF-kappaB transcription factor activity GO:0051092
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor NF-kappaB.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Protein complex oligomerization GO:0051259
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
2 O95999 (/IPI) O95999 (/IPI)
Protein complex oligomerization GO:0051259
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers; protein oligomers may be composed of different or identical monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Protein homooligomerization GO:0051260
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
2 Q9Z0H7 (/IMP) Q9Z0H7 (/IMP)
Protein homooligomerization GO:0051260
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
2 O95999 (/TAS) O95999 (/TAS)
Protein heterooligomerization GO:0051291
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers that are not all identical. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
T cell apoptotic process GO:0070231
Any apoptotic process in a T cell, a type of lymphocyte whose defining characteristic is the expression of a T cell receptor complex.
2 Q9Z0H7 (/IDA) Q9Z0H7 (/IDA)
Cellular response to mechanical stimulus GO:0071260
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a mechanical stimulus.
2 O95999 (/IEP) O95999 (/IEP)
Positive regulation of execution phase of apoptosis GO:1900119
Any process that activates or increases the frequency, rate or extent of execution phase of apoptosis.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Positive regulation of extrinsic apoptotic signaling pathway GO:2001238
Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Protein heterooligomerization GO:0051291
The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of component monomers that are not all identical. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.
1 Q9QYN5 (/IPI)

There are 28 GO terms relating to "cellular component"

The search results have been sorted with the annotations that are found most frequently at the top of the list. The results can be filtered by typing text into the search box at the top of the table.
GO Term Annotations Evidence
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Lysosome GO:0005764
A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
9 E7EC82 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q17QJ6 (/ISS) Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
5 E7F8A6 (/IDA) O95999 (/IDA) O95999 (/IDA) Q9Z0H7 (/IDA) Q9Z0H7 (/IDA)
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
5 O95999 (/IDA) O95999 (/IDA) Q9QYN5 (/IDA) Q9Z0H7 (/IDA) Q9Z0H7 (/IDA)
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
4 O95999 (/TAS) O95999 (/TAS) Q9Z0H7 (/TAS) Q9Z0H7 (/TAS)
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
4 O95999 (/IDA) O95999 (/IDA) Q9QYN5 (/IDA) R4GI14 (/IDA)
Cytoplasmic microtubule GO:0005881
Any microtubule in the cytoplasm of a cell.
3 Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
CBM complex GO:0032449
A protein complex comprising Carma1, Bcl10 and MALT1; plays a role in signal transduction during NF-kappaB activation.
3 E7F8A6 (/IDA) O95999 (/IDA) O95999 (/IDA)
CBM complex GO:0032449
A protein complex comprising Carma1, Bcl10 and MALT1; plays a role in signal transduction during NF-kappaB activation.
3 Q9QYN5 (/ISS) Q9Z0H7 (/ISS) Q9Z0H7 (/ISS)
Immunological synapse GO:0001772
An area of close contact between a lymphocyte (T-, B-, or natural killer cell) and a target cell formed through the clustering of particular signaling and adhesion molecules and their associated membrane rafts on both the lymphocyte and the target cell and facilitating activation of the lymphocyte, transfer of membrane from the target cell to the lymphocyte, and in some situations killing of the target cell through release of secretory granules and/or death-pathway ligand-receptor interaction.
2 Q9Z0H7 (/IDA) Q9Z0H7 (/IDA)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
2 O95999 (/IDA) O95999 (/IDA)
Nucleus GO:0005634
A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Lysosome GO:0005764
A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
2 O95999 (/IDA) O95999 (/IDA)
Lysosome GO:0005764
A small lytic vacuole that has cell cycle-independent morphology and is found in most animal cells and that contains a variety of hydrolases, most of which have their maximal activities in the pH range 5-6. The contained enzymes display latency if properly isolated. About 40 different lysosomal hydrolases are known and lysosomes have a great variety of morphologies and functions.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Cytoplasmic microtubule GO:0005881
Any microtubule in the cytoplasm of a cell.
2 O95999 (/IDA) O95999 (/IDA)
Cytoplasmic microtubule GO:0005881
Any microtubule in the cytoplasm of a cell.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
CBM complex GO:0032449
A protein complex comprising Carma1, Bcl10 and MALT1; plays a role in signal transduction during NF-kappaB activation.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
CBM complex GO:0032449
A protein complex comprising Carma1, Bcl10 and MALT1; plays a role in signal transduction during NF-kappaB activation.
2 O95999 (/NAS) O95999 (/NAS)
Protein-containing complex GO:0032991
A stable assembly of two or more macromolecules, i.e. proteins, nucleic acids, carbohydrates or lipids, in which at least one component is a protein and the constituent parts function together.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)
Membrane raft GO:0045121
Any of the small (10-200 nm), heterogeneous, highly dynamic, sterol- and sphingolipid-enriched membrane domains that compartmentalize cellular processes. Small rafts can sometimes be stabilized to form larger platforms through protein-protein and protein-lipid interactions.
2 Q9Z0H7 (/IDA) Q9Z0H7 (/IDA)
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
2 O95999 (/IDA) O95999 (/IDA)
Perinuclear region of cytoplasm GO:0048471
Cytoplasm situated near, or occurring around, the nucleus.
2 Q9Z0H7 (/ISO) Q9Z0H7 (/ISO)